These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21981948)

  • 1. A diagnostic challenge for Schistosomiasis japonica in China: consequences on praziquantel-based morbidity control.
    Zhou YB; Zheng HM; Jiang QW
    Parasit Vectors; 2011 Oct; 4():194. PubMed ID: 21981948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of praziquantel in schistosomiasis japonica control strategies in China.
    Wu W; Huang Y
    Parasitol Res; 2013 Mar; 112(3):909-15. PubMed ID: 23358736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience.
    Chen MG
    Acta Trop; 2005; 96(2-3):168-76. PubMed ID: 16125657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA detection of Schistosoma japonicum: diagnostic validity of a LAMP assay for low-intensity infection and effects of chemotherapy in humans.
    Xu J; Guan ZX; Zhao B; Wang YY; Cao Y; Zhang HQ; Zhu XQ; He YK; Xia CM
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003668. PubMed ID: 25874964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effectiveness of the integrated schistosomiasis control strategy with emphasis on infectious source control in China: a 10-year evaluation from 2005 to 2014.
    Wang X; Wang W; Wang P
    Parasitol Res; 2017 Feb; 116(2):521-528. PubMed ID: 27812902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serodiagnosis of Schistosoma japonicum infection: genome-wide identification of a protein marker, and assessment of its diagnostic validity in a field study in China.
    Xu X; Zhang Y; Lin D; Zhang J; Xu J; Liu YM; Hu F; Qing X; Xia C; Pan W
    Lancet Infect Dis; 2014 Jun; 14(6):489-97. PubMed ID: 24656567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-component integrated approach for the elimination of schistosomiasis in the People's Republic of China: design and baseline results of a 4-year cluster-randomised intervention trial.
    Gray DJ; Li YS; Williams GM; Zhao ZY; Harn DA; Li SM; Ren MY; Feng Z; Guo FY; Guo JG; Zhou J; Dong YL; Li Y; Ross AG; McManus DP
    Int J Parasitol; 2014 Aug; 44(9):659-68. PubMed ID: 24929133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sensitivity of Schistosoma japonicum to praziquantel: a field evaluation in areas with low endemicity of China.
    Wang W; Dai JR; Li HJ; Shen XH; Liang YS
    Am J Trop Med Hyg; 2012 May; 86(5):834-6. PubMed ID: 22556083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of schistosomiasis japonica from formerly endemic areas in mountainous regions of southern China using a praziquantel regimen.
    Li H; Dong GD; Liu JM; Gao JX; Shi YJ; Zhang YG; Jin YM; Lu K; Cheng GF; Lin JJ
    Vet Parasitol; 2015 Mar; 208(3-4):254-8. PubMed ID: 25591407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analyses of Schistosoma japonicum infections in wild rodents across China over time indicates a potential challenge to the 2030 elimination targets.
    Zou HY; Yu QF; Qiu C; Webster JP; Lu DB
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008652. PubMed ID: 32877407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in prevalence, intensity of infection and morbidity due to Schistosoma japonicum infection in a community following a single treatment with praziquantel.
    Zhao G; Jiang Q; Wasley A; Zhang S; ljWu Z; Liu Z; Yuan H
    Trop Geogr Med; 1995; 47(6):289-92. PubMed ID: 8650742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Schistosomiasis japonica in a patient who emigrated from China: a case report].
    Machida K; Yamada T; Shimura E; Umemura M; Onoue S; Kaneko M; Mabuchi H; Takahashi Y; Sasada Y; Saida Y
    Nihon Shokakibyo Gakkai Zasshi; 2018; 115(12):1094-1100. PubMed ID: 30531116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there reduced susceptibility to praziquantel in Schistosoma japonicum? Evidence from China.
    Wang W; Dai JR; Li HJ; Shen XH; Liang YS
    Parasitology; 2010 Nov; 137(13):1905-12. PubMed ID: 20810006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Application of Diagnostics in the National Schistosomiasis Control Programme in The People's Republic of China.
    Zhang JF; Xu J; Bergquist R; Yu LL; Yan XL; Zhu HQ; Wen LY
    Adv Parasitol; 2016; 92():409-34. PubMed ID: 27137454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schistosomiasis in China.
    Mao SP; Fu S
    Prog Clin Parasitol; 1989; 1():121-41. PubMed ID: 2518837
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiological features and control strategies of schistosomiasis japonica in China.
    Yuan HC
    Chin Med J (Engl); 1993 Aug; 106(8):563-8. PubMed ID: 8222903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year impact of praziquantel treatment for Schistosoma japonicum infection in China: re-infection, subclinical disease and fibrosis marker measurements.
    Li YS; Sleigh AC; Ross AG; Li Y; Williams GM; Tanner M; McManus DP
    Trans R Soc Trop Med Hyg; 2000; 94(2):191-7. PubMed ID: 10897367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical diagnostic value of viable Schistosoma japonicum eggs detected in host tissues.
    Gu K; Li Y; Driguez P; Zeng Q; Yu X; Sun H; Cai L; He Y; Wang W; McManus DP
    BMC Infect Dis; 2017 Apr; 17(1):244. PubMed ID: 28376858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody isotype responses to Schistosoma japonicum antigens in subjects from a schistosomiasis area with repeated praziquantel chemotherapy compared with a new endemic zone in Hunan Province, P.R. China.
    Li Y; Yu DB; Li YS; Luo XS; Liang YS; Bartley PB; McManus DP
    Trans R Soc Trop Med Hyg; 2002; 96(2):210-5. PubMed ID: 12055818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Schistosoma japonicum in China: morbidity and strategies for control in the Dongting Lake region.
    Li YS; Sleigh AC; Ross AG; Williams GM; Tanner M; McManus DP
    Int J Parasitol; 2000 Mar; 30(3):273-81. PubMed ID: 10719120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.